Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antibody-based technology that enables specifically inhibit monocyte migration for immune-inflammatory applications. The company's lead product candidate is VB-111, a gene-based biologic that is in Phase III clinical trials for the recurrent platinum-resistant ovarian cancer; and Phase II clinical trials treatment of recurrent glioblastoma and colorectal cancer, as well as has completed Phase II clinical trial for the treatment of thyroid cancer. It is also developing VB-601 for various inflammatory indications, and VB-611 for various solid tumors. The company was formerly known as Medicard Ltd. and changed its name to Vascular Biogenics Ltd. in January 2003. Vascular Biogenics Ltd. was incorporated in 2000 and is headquartered in Modi'in, Israel.

CEO

Dror Harats

Employees

Country

Israel

ISIN

IL0012002452

Listings

OTC Link

NTBLQ

0 Comments

Share your thoughts

FAQ

What is Notable Labs stock price today?▼

The current price of NTBLQ is $0 USD — it has increased by +0% in the past 24 hours. Watch Notable Labs stock price performance more closely on the chart.

What is Notable Labs stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Notable Labs stocks are traded under the ticker NTBLQ.

Is Notable Labs stock price growing?▼

NTBLQ stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Notable Labs has showed a -90% decrease.

What is Notable Labs market cap?▼

Today Notable Labs has the market capitalization of 96.59

What is Notable Labs revenue for the last year?▼

Notable Labs revenue for the last year amounts to 620,000 USD.

What is Notable Labs net income for the last year?▼

NTBLQ net income for the last year is -22.53M USD.

How many employees does Notable Labs have?▼

As of April 12, 2026, the company has 41 employees.

In which sector is Notable Labs located?▼

Notable Labs operates in the Manufacturing sector.

When did Notable Labs complete a stock split?▼

Notable Labs has not had any recent stock splits.

Where is Notable Labs headquartered?▼

Notable Labs is headquartered in 8 Hasatat St, Israel.